Drug
Zonisamide
Zonisamide: highest development phase Phase 3, developed by Eisai. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Eisai
Trials
| Drug | Phase | Indication |
|---|---|---|
| Zonisamide NCT00692003 | Phase 3 | Epilepsy |
Latest
No recent events.
Follow Zonisamide on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.